308 related articles for article (PubMed ID: 22835738)
1. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
van Riet E; Ainai A; Suzuki T; Hasegawa H
Vaccine; 2012 Aug; 30(40):5893-900. PubMed ID: 22835738
[TBL] [Abstract][Full Text] [Related]
2. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
3. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
Cherukuri A; Servat E; Woo J
Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
6. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
8. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
Sha Z; Kang SM; Compans RW
Virology; 2005 Jan; 331(2):387-95. PubMed ID: 15629781
[TBL] [Abstract][Full Text] [Related]
10. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.
Chen CY; Liu HJ; Tsai CP; Chung CY; Shih YS; Chang PC; Chiu YT; Hu YC
Vaccine; 2010 Nov; 28(48):7644-51. PubMed ID: 20883735
[TBL] [Abstract][Full Text] [Related]
11. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
[TBL] [Abstract][Full Text] [Related]
12. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
13. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.
Bonduelle O; Yahia N; Siberil S; Benhabiles N; Carrat F; Krivine A; Rozenberg F; Dimitrov J; Kaveri SV; Curjol A; Tindel M; Louet M; Desert F; Launay O; Loulergue P; Badre G; Katlama C; Bricaire F; Samri A; Rousset D; van der Werf S; Jauréguiberry S; Combadiere B
J Immunol; 2013 Jul; 191(2):623-31. PubMed ID: 23776176
[TBL] [Abstract][Full Text] [Related]
15. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunity to influenza without IgA: an IgA knockout mouse model.
Mbawuike IN; Pacheco S; Acuna CL; Switzer KC; Zhang Y; Harriman GR
J Immunol; 1999 Mar; 162(5):2530-7. PubMed ID: 10072492
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
18. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
[TBL] [Abstract][Full Text] [Related]
19. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
[TBL] [Abstract][Full Text] [Related]
20. Role of mucosal immunity in influenza.
Brandtzaeg P
Dev Biol (Basel); 2003; 115():39-48. PubMed ID: 15088774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]